These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 107050)

  • 1. Effect of active and passive antibacterial immunization on skin allograft survival in rabbits.
    Liska M; Hatala M
    Folia Biol (Praha); 1979; 25(1):70-5. PubMed ID: 107050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between immune response to gram-negative intestinal rods and allotransplantation reaction.
    Liska M; Hatala M; Vrubel J
    Folia Biol (Praha); 1973; 19(2):101-6. PubMed ID: 4573339
    [No Abstract]   [Full Text] [Related]  

  • 3. [Obtaining the homologous hyperimmune preparations from the blood of immunized donors - anti-coli (anti-Escherichia) and antitoxic antipyocyanotic plasma].
    Skurkovich SV; Likhoded VG; Krokhina MA; Temper RM; Demidova NV
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):51-3. PubMed ID: 417340
    [No Abstract]   [Full Text] [Related]  

  • 4. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
    Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
    Lieberman MM; Ayala E
    J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral immunization against colienteritis with streptomycin-dependent E. coli. II. Comparison of the effectivity of vaccines from live streptomycin-dependent and killed EC-0111 B4 bacteria by testing the agglutinin formation in mice and rabbits, the bactericidal activity of rabbit serums and the passive protection trial in mice].
    Koch H; Linde K; Kittlick M; Stelzner A
    Zentralbl Bakteriol Orig; 1969; 211(4):466-75. PubMed ID: 4916987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protective effect of coli-proteus vaccine in an experimental animal model].
    Bĕlohlávek S; Konícková L
    Cesk Farm; 1980 May; 29(3-4):95-9. PubMed ID: 6996844
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the specificity of antisera against denaturated desoxyribonucleic acids].
    Störl HJ; Simon H; Barthelmes H
    Acta Biol Med Ger; 1974; 33(4):485-95. PubMed ID: 4219522
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection against Gram-negative infection by 'super-active' antigen.
    Roe EA
    Immunology; 1976 Nov; 31(5):707-15. PubMed ID: 825449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of the course of the immune response at the urinary level following repeated oral vaccination].
    Negretti F; Casetta P
    Minerva Med; 1990 Nov; 81(11):791-800. PubMed ID: 2123973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of anti-immunoglobulin serum on skin allograft survival in mice.
    Skopińska E; Mościcka-Wesołowska M; Nowicka E; Bucholc B
    Bull Acad Pol Sci Biol; 1979; 27(12):1011-4. PubMed ID: 399868
    [No Abstract]   [Full Text] [Related]  

  • 12. [Obtaining antisera to Pseudomonas aeruginosa and Proteus antigens for performing immunoenzyme analyses in clinical practice].
    Bulava GV; Ermolin GA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):51-5. PubMed ID: 3920845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of antisera against homologous and heterologous Escherichia coli of porcine origin.
    Enweani CC; Gyles CL; Barnum DA
    Can J Comp Med; 1975 Jan; 39(1):54-61. PubMed ID: 46176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunity of the skin--infection and percutaneous immunization of rabbits with E. coli ATCC 13676].
    Hammerschmidt W; Hellmann E
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):252-67. PubMed ID: 3892981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    McCabe WR
    J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibacterial activity of crude methanolic extract and its fractions of aerial parts of Anthemis tinctoria.
    Akgul C; Saglikoglu G
    Indian J Biochem Biophys; 2005 Dec; 42(6):395-7. PubMed ID: 16955742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vaccination against Porteus mirabilis.
    Jones RJ
    Br J Exp Pathol; 1976 Aug; 57(4):395-9. PubMed ID: 822863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model.
    Lieberman MM; Walker HL; Ayala E; Chapa I
    J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):177-84. PubMed ID: 2467637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa. Vaccines and immunotherapy.
    Pennington JE
    Infect Dis Clin North Am; 1990 Jun; 4(2):259-70. PubMed ID: 2111838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.